Regulatory Filings • Oct 15, 2019
Regulatory Filings
Open in ViewerOpens in native device viewer

The tablets are toughbooks and will be used to run Ortivus' MobiMed. Half of the tablets comes from Panasonic and half of them from Getac. The new tablets will be installed in new ambulances and used to evaluate suitable platforms for future use.
SCAS is serving a population of 4 million people and has over 500 patient transport service vehicles. The value of the order is approx. £170.000.
För further information, please contact
Reidar Gårdebäck, CEO
Telefon +46 8 446 45 00
Ortivus was founded in 1985, based on clinical experience in cardiology, and has its headquarters in Danderyd, outside Stockholm. The company has had a presence in the UK through its own subsidiary since 1998. Through its proprietary, module-based MobiMed technology platform, Ortivus offers its customers real-time monitoring of patients in prehospital care and MobiMed ePR – a decision support system that can be integrated in real time with patient management systems in the healthcare setting and with external patient systems. Ortivus Class A and Class B shares are listed on the NASDAQ Stockholm Small Cap list.
Read more about Ortivus at www.ortivus.com
This information is information that Ortivus is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2019-10-15 09:15 CEST.
Ortivus has received an order to equip new vehicles that SCAS are procuring with new ePCR devices for MobiMed
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.